C 
Cooper Companies COO · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
63.93
+2.52%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$4.09bn
FY2016FY2025
Net income
$374.9m
FY2016FY2025
Free cash flow
$433.7m
FY2016FY2025
Shareholders' equity
$8.24bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.09bn | $3.90bn | $3.59bn | $3.31bn | $2.92bn | $2.43bn | $2.65bn | $2.53bn | $2.14bn | $1.97bn |
| Gross profit | $2.48bn | $2.60bn | $2.36bn | $2.14bn | $1.96bn | $1.53bn | $1.76bn | $1.63bn | $1.37bn | $1.17bn |
| Research and development | $172.2m | $155.1m | $137.4m | $110.3m | $92.7m | $93.3m | $86.7m | $84.8m | $69.2m | $65.4m |
| Operating income | $682.9m | $705.7m | $533.1m | $507.6m | $505.8m | $311.8m | $546.7m | $403.1m | $429.1m | $324.1m |
| Net income | $374.9m | $392.3m | $294.2m | $385.8m | $2.94bn | $238.4m | $466.7m | $139.9m | $372.9m | $273.9m |
| Diluted earnings per share | 1.89 | 1.95 | 1.47 | 1.94 | 14.75 | 1.20 | 2.33 | 0.70 | 1.88 | 1.39 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12.39bn | $12.32bn | $11.66bn | $11.49bn | $9.61bn | $6.74bn | $6.27bn | $6.11bn | $4.86bn | $4.48bn |
| Cash and short-term investments | $110.6m | $107.6m | $120.8m | $138.2m | $95.9m | $115.9m | $89.0m | $77.7m | $88.8m | $100.8m |
| Total liabilities | $4.16bn | $4.23bn | $4.11bn | $4.32bn | $2.66bn | $2.91bn | $2.65bn | $2.81bn | $1.68bn | $1.78bn |
| Debt | $2.51bn | $2.58bn | $2.57bn | $2.76bn | $1.48bn | $1.79bn | $1.83bn | $2.02bn | $1.17bn | $1.33bn |
| Shareholders' equity | $8.24bn | $8.08bn | $7.55bn | $7.17bn | $6.94bn | $3.82bn | $3.63bn | $3.31bn | $3.18bn | $2.70bn |
| Shares outstanding | 198m | 201m | 200m | 198m | 200m | 198m | 200m | 200m | 199m | 197m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $796.1m | $709.3m | $607.5m | $692.4m | $738.6m | $486.6m | $713.2m | $668.9m | $593.6m | $509.6m |
| Capital spending | −$362.4m | −$421.2m | −$392.5m | −$242.0m | −$214.4m | −$310.4m | −$292.1m | −$193.6m | −$127.2m | −$152.6m |
| Free cash flow | $433.7m | $288.1m | $215.0m | $450.4m | $524.2m | $176.2m | $421.1m | $475.3m | $466.4m | $357.0m |
| Dividends paid | — | — | −$3.0m | −$3.0m | −$3.0m | −$3.0m | −$3.0m | −$2.9m | −$2.9m | −$2.9m |
Latest quarters
By quarter end
| Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07bn | $1.08bn | $1.02bn | $1.07bn | $1.06bn | $1.00bn | $964.7m | $1.02bn |
| Gross profit | $664.9m | $735.4m | $695.2m | $601.0m | $692.0m | $679.1m | $660.2m | $677.7m |
| Operating income | $222.4m | −$27.5m | $212.8m | $140.4m | $175.7m | $184.8m | $182.0m | $198.4m |
| Net income | $432.8m | −$77.9m | $130.8m | $84.6m | $98.3m | $87.7m | $104.3m | $117.5m |
| Diluted earnings per share | 2.24 | -0.40 | 0.68 | 0.43 | 0.50 | 0.44 | 0.53 | 0.58 |
| Cash from operations | $341.0m | $182.0m | $260.0m | $247.0m | $261.0m | $96.0m | $190.0m | $268.0m |
| Capital spending | −$194.0m | −$86.0m | −$102.0m | −$98.0m | −$96.0m | −$78.0m | −$89.0m | −$140.0m |
| Free cash flow | $147.0m | $96.0m | $158.0m | $149.0m | $165.0m | $18.0m | $101.0m | $128.0m |
| Total assets | $12.67bn | $12.48bn | $12.42bn | $12.39bn | $12.38bn | $12.41bn | $12.22bn | $12.32bn |
| Cash and short-term investments | $154.7m | $138.8m | $124.9m | $110.6m | $124.9m | $116.2m | $100.9m | $107.6m |
| Debt | $628.1m | $2.46bn | $2.50bn | $2.54bn | $2.48bn | $2.58bn | $2.54bn | $2.58bn |
| Shareholders' equity | $8.33bn | $8.24bn | $8.36bn | $8.24bn | $8.35bn | $8.29bn | $8.13bn | $8.08bn |
Financial ratios
Data as of 29 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 60.7% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% |
| Operating margin | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% |
| Net margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% |
| Return on equity | 4.6% | 4.9% | 3.9% | 5.4% | 42.4% | 6.2% |
| Return on assets | 3.0% | 3.2% | 2.5% | 3.4% | 30.7% | 3.5% |
| Free cash flow yield | 10.3% | 9.9% | 8.9% | 8.3% | 8.4% | 7.1% |
| Revenue growth | 5.1% | 8.4% | 8.6% | 13.2% | 20.2% | -8.4% |
| Earnings growth | -4.4% | 33.3% | -23.7% | -86.9% | 1135.2% | -48.9% |
| Current ratio | 1.89x | 1.91x | 1.76x | 1.20x | 2.00x | 1.27x |
| Debt to equity | 0.31x | 0.32x | 0.34x | 0.39x | 0.21x | 0.48x |
| Equity ratio | 66.5% | 65.6% | 64.8% | 62.4% | 72.3% | 56.8% |
| Interest coverage | 6.83x | 6.17x | 5.06x | 8.86x | 21.90x | 8.47x |
| R&D as a share of sales | 4.2% | 4.0% | 3.8% | 3.3% | 3.2% | 3.8% |
| Buybacks as a share of market value | 1.5% | -0.8% | -0.6% | 0.6% | -0.6% | 0.8% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 7.3% | 11.0% | 8.6% |
| Operating income | 10.4% | 17.0% | 11.2% |
| Net income | -1.0% | 9.5% | 6.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 63.6% | 64.3% | 64.5% | 64.0% |
| Operating margin | 17.4% | 16.3% | 16.0% | 16.6% |
| Net margin | 9.6% | 9.7% | 22.9% | 19.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 43.3 | 47.1 | 64.2 | 42.5 | 7.1 | 75.6 | 34.4 | 90.8 | 29.0 | 31.5 |
| Price to sales | 4.0 | 4.8 | 5.3 | 5.0 | 7.2 | 7.4 | 6.0 | 5.0 | 5.1 | 4.4 |
Market value over time
31 Oct 2016 to 28 Sept 2026, in USD
$8.63bn$10.94bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -11% | 1% | 16% | -19% | 12% | 9% | 35% | 5% | 28% | 33% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 26 Jul 2023.
| FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 |
- 4-for-1 split · 20 Feb 2024
- 2-for-1 split · 25 Nov 2002
- 3-to-1 reverse split · 22 Sept 1995
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.